$CAH

CARDINAL HEALTH INC

Cardinal Health, based in Dublin, Ohio, serves healthcare organizations and patients through pharmaceutical and medical product distribution and related services. Its offerings include branded, generic and specialty medicines, pharmacy management, and services for drug manufacturers and healthcare providers. The company also supplies medical, surgical and laboratory goods, including products under its own brand, and provides supply chain support, procedure kits and radiopharmaceutical preparation and delivery for hospitals, pharmacies, clinics and other care settings.

AlphAI earnings readFirst Quarter Fiscal Year 2027 · NOV 5Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises OutlookVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

4
3
0

No SEC Form 4 filings for $CAH in the last 30 days.

See all $CAH insider activity →
Low

Jim Cramer's top 10 things to watch in the stock market Tuesday

Jim Cramer highlights key market events: Nvidia's earnings anticipation, Home Depot's Q3 beat, Disney's cost-cutting plans, Nucor's upgrades, Tyson Foods' downgrade, and price target changes for Regeneron, Cardinal Health, T-Mobile, and Kimberly-Clark.

Wells Fargo raises Cardinal Health stock price target on pharma strength

Wells Fargo raised its price target for Cardinal Health (CAH) to $321 from $277, citing strength in its pharmaceutical and other segments. The stock trades at $283.85. Analysts increased EPS estimates for 2027 and 2028. Cardinal Health reported strong Q1 results, with EPS up 28% and revenue up 5%, and raised its full-year profit outlook.

CARDINAL HEALTH INC (CAH): Submission of Matters to a Vote of Security Holders

CARDINAL HEALTH INC (CAH) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. Cardinal Health, Inc. (the "Company") held its 2026 Annual Meeting of Shareholders (the "Annual Meeting") on November 12, 2026. See the Company’s definitive proxy statement for the Annual Meeting filed with the Secur

CAH sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 7 news stories mentioning CAH (CARDINAL HEALTH INC). Coverage has skewed bullish: 4 bullish, 3 neutral, and 0 bearish.

Recent CAH coverage spans financial news, market movers and corporate actions.

What's driving CAH

AlphAI scores every news story that mentions CAH with an AI model for sentiment and relevance, and aggregates insider trades from CARDINAL HEALTH INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CAH

Score
$CAHLowShareholder vote

CARDINAL HEALTH INC (CAH): Submission of Matters to a Vote of Security Holders

CARDINAL HEALTH INC (CAH) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. Cardinal Health, Inc. (the "Company") held its 2026 Annual Meeting of Shareholders (the "Annual Meeting") on November 12, 2026. See the Company’s definitive proxy statement for the Annual Meeting filed with the Secur

$CAHHighAI 8/10

Argus raises Cardinal Health stock price target on strong earnings

Argus raised its price target for Cardinal Health (CAH) to $309 from $264, citing strong Q1 2027 results. The company reported 5% revenue growth and 28% adjusted EPS growth to $3.26, exceeding estimates. Cardinal Health also raised its fiscal 2027 adjusted EPS guidance to $12.80-$13.00. The stock is near its 52-week high, up 53% in six months, and is considered undervalued by InvestingPro.

Can Cardinal Health Stock Repeat Its Last Five Years?

Cardinal Health (CAH) stock rose 454.6% from September 2021 to November 2026, with sales growth of 54% to $258 billion. The stock's rise was largely driven by an increase in its price-to-earnings multiple, which rose from 12.6 to 35.2, and a 19.4% reduction in share count due to buybacks. The company's net margin remained relatively stable.

Jim Cramer’s Charitable Trust Plans to Trim Cardinal Health and Eli Lilly

Jim Cramer’s Charitable Trust plans to reduce its holdings in Cardinal Health (CAH) and Eli Lilly (LLY) after both stocks rose over 20% since late September. The trust will sell 50 CAH shares at ~$273 each and 10 LLY shares at ~$1,420 each, reducing their portfolio weightings. Both companies recently reported stronger-than-expected earnings and raised outlooks.

Related tickers